VYNE Therapeutics Inc.

Q2 2023 13F Holders

Symbol: VYNE
CUSIP: 92941V308
Type: Equity
Class: COM
Num filings: 20
Total reported value, excl. options: $1.53 M

Compare 2023 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type